Heterologous Expression and Characterization of Estercin A, a Class II Lanthipeptide Derived from <i>Clostridium estertheticum</i> CF016, with Antimicrobial Activity against Clinically Relevant Pathogens. [PDF]
Wang C +6 more
europepmc +1 more source
Beneficial perspective on <i>Staphylococcus epidermidis</i>: a crucial species for skin homeostasis and pathogen defense. [PDF]
Qi P, Gong F, Leng M, Wei Z.
europepmc +1 more source
Activity of Gut-Derived Nisin-like Lantibiotics against Human Gut Pathogens and Commensals. [PDF]
Zhang ZJ +8 more
europepmc +1 more source
Biosynthesis of Antimicrobial Ornithine-Containing Lacticin 481 Analogues by Use of a Combinatorial Biosynthetic Pathway in <i>Escherichia coli</i>. [PDF]
Xu Y, Reuvekamp R, Kuipers OP.
europepmc +1 more source
Eliciting Clavulanic Acid Biosynthesis: The Impact of <i>Bacillus velezensis</i> FZB42 on the Metabolism of <i>Streptoyces clavuligerus</i> ATCC 27064. [PDF]
Patiño LF +4 more
europepmc +1 more source
Biopreservation strategies using bacteriocins to control meat spoilage and foodborne outbreaks. [PDF]
Fernandes N +3 more
europepmc +1 more source
Insights into the production and evolution of lantibiotics from a computational analysis of peptides associated with the lanthipeptide cyclase domain. [PDF]
Maheshwari N +4 more
europepmc +1 more source
Commercial utilization of bacteriocins: tackling challenges and exploring their potential as alternatives to antibiotics. [PDF]
Selvan SA +3 more
europepmc +1 more source
Current status and potential of bacteriocin-producing lactic acid bacteria applied in the food industry. [PDF]
Liang Q +6 more
europepmc +1 more source
Bibacillin 1: a two-component lantibiotic from <i>Bacillus thuringiensis</i>. [PDF]
Moreira R +4 more
europepmc +1 more source

